Douglas M. Van Oort - Aug 1, 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Director
Signature: /s/ Douglas M. VanOort
Stock symbol: NEO
Transactions as of: Aug 1, 2021
Transactions value $: -$272,866
Form type: 4
Date filed: 8/13/2021, 05:12 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Tax liability	-$273K	-5.92K	-0.24%	$46.10	2.47M	Aug 1, 2021	Direct	F1
holding	NEO	Common Stock						15K	Aug 1, 2021	Custodial Account for Child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)						500K	Aug 1, 2021	Common Stock	500K	$8.03	Direct	F2
holding	NEO	Stock Option (Right to Buy)						232K	Aug 1, 2021	Common Stock	232K	$19.60	Direct	F3
holding	NEO	Stock Option (Right to Buy)						225K	Aug 1, 2021	Common Stock	225K	$28.33	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the August 1, 2021 vesting of restricted stock.
F2	On February 26, 2018, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F3	On March 1, 2019, Mr. VanOort was granted 231,567 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4	On March 2, 2020, Mr. VanOort was granted 225,084 stock options. These options vest ratably over the first four anniversary dates of the grant date.